Our Science

Innovative Therapeutic Areas

At Teva, our pioneering mindset - grounded in both ambition and commitment - drives us to develop treatments that can enhance care, improve patients’ quality of life, and meet the needs of healthcare providers.

Our innovative medicines research focuses on neuroscience and immunology, where we pursue solutions for common and rare diseases with significant unmet needs.

 

Neuroscience

Teva’s commitment to supporting patients with neurological conditions stretches back over 30 years, when we brought our first innovative treatment to market. Today, we are advancing multiple medicines for neurological conditions, drawing on the deep scientific expertise, diverse capabilities, and global reach of our R&D organization.

In neuroscience, we focus on movement disorders, mental health conditions and migraine. Our work includes Huntington’s disease chorea, tardive dyskinesia (TD), schizophrenia, Tourette Syndrome, multiple system atrophy (MSA), and Parkinson’s disease (PD).

Mental Health Conditions

Our neuroscience research addresses severe and enduring mental health conditions, with a focus on advancing innovative solutions where unmet needs remain.

Learn more

Migraine

We focus on therapies designed to support people living with chronic and episodic migraine, helping them regain control of their daily activities.

Learn more

Movement Disorders

We advance innovative treatments for movement disorders to improve patients' quality of life and support the long-term management of their conditions.

Learn more

Immunology

In immunology, we focus on a range of therapeutic areas including gastroenterology, respiratory medicine, and dermatology. Our efforts include developing treatments for inflammatory bowel disease, asthma, celiac disease, vitiligo and more.

Inflammatory bowel disease

Inflammatory bowel disease (IBD) is a chronic condition that affects the digestive system.

Learn more

Celiac disease

Celiac disease is an autoimmune condition in which gluten damages the small intestine and impairs nutrient absorption.

Learn more

Vitiligo

Vitiligo is a chronic autoimmune disease that causes patches of skin to lose pigment or color.

Learn more

Respiratory conditions

Our focus includes asthma, a chronic respiratory condition characterized by inflammation and narrowing of the airways that can make breathing difficult.

Learn more
Eric Hughes, Head of Global R&D and Chief Medical Officer

"For people living with complex conditions, time matters. By bringing together scientific expertise, thoughtful clinical development and cross-functional collaboration, we can accelerate progress and deliver meaningful medicines to patients faster."

Eric Hughes, MD, PhD
Head of Global R&D and Chief Medical Officer

NPS-ALL-NP-01872 November 2026